Stocks
Funds
Screener
Sectors
Watchlists
ELV

ELV - Elevance Health, Inc. Stock Price, Fair Value and News

$341.86+18.94 (+5.87%)
Market Closed

80/100

ELV

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

80/100

ELV

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$556.59

Target 3M

$411.51

Target 6M

$456.4

ELV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ELV Price Action

Last 7 days

-7.6%

Last 30 days

-1.9%

Last 90 days

6.2%

Trailing 12 Months

-15.7%

ELV RSI Chart

ELV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ELV Valuation

Market Cap

75.9B

Price/Earnings (Trailing)

13.72

Price/Sales (Trailing)

0.39

EV/EBITDA

11.39

Price/Free Cashflow

20.15

ELV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$556.59

Target 3M

$411.51

Target 6M

$456.4

ELV Fundamentals

ELV Revenue

Revenue (TTM)

194.8B

Rev. Growth (Yr)

12.43%

Rev. Growth (Qtr)

1.88%

ELV Earnings

Earnings (TTM)

5.5B

Earnings Growth (Yr)

17.03%

Earnings Growth (Qtr)

-31.82%

ELV Profitability

EBT Margin

3.64%

Return on Equity

12.59%

Return on Assets

4.51%

Free Cashflow Yield

4.96%

ELV Investor Care

Dividend Yield

1.98%

Dividend/Share (TTM)

6.76

Buy Backs (1Y)

4.27%

Diluted EPS (TTM)

24.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025183.3B189.2B194.8B0
2024171.7B172.0B174.2B177.0B
2023160.7B165.7B168.6B171.3B
2022144.3B149.1B153.2B156.6B
2021124.6B129.2B133.9B138.6B
2020109.2B113.0B117.5B121.9B
201994.2B96.8B100.2B104.2B
201890.1B90.6B91.4B92.1B
201787.1B88.1B89.1B90.0B
201680.4B81.8B83.3B84.9B
201575.1B76.6B78.0B79.2B
201471.3B72.1B72.8B73.9B
201363.7B66.0B68.6B71.0B
201261.2B61.5B61.4B61.5B
201158.5B59.2B60.0B60.7B
201000058.7B
ELV
Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.
 CEO
 WEBSITEelevancehealth.com
 SECTORHealthcare
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

Elevance Health, Inc. Frequently Asked Questions


ELV is the stock ticker symbol of Elevance Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Elevance Health, Inc. is 75.91 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ELV's fair value in chart for subscribers.

The fair value guage provides a quick view whether ELV is over valued or under valued. Whether Elevance Health, Inc. is cheap or expensive depends on the assumptions which impact Elevance Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ELV.

As of Wed Jan 28 2026, ELV's PE ratio (Price to Earnings) is 13.72 and Price to Sales (PS) ratio is 0.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ELV PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Elevance Health, Inc. has provided 0.101 (multiply by 100 for percentage) rate of return.